GR1000303B - Μια νεα συνθεση επικαλυψεως καταλληλη για χρηση επι φαρμακων με την μορφη ζαχαροπηκτων. - Google Patents
Μια νεα συνθεση επικαλυψεως καταλληλη για χρηση επι φαρμακων με την μορφη ζαχαροπηκτων.Info
- Publication number
- GR1000303B GR1000303B GR880100297A GR880100297A GR1000303B GR 1000303 B GR1000303 B GR 1000303B GR 880100297 A GR880100297 A GR 880100297A GR 880100297 A GR880100297 A GR 880100297A GR 1000303 B GR1000303 B GR 1000303B
- Authority
- GR
- Greece
- Prior art keywords
- mixture
- composition
- fat
- preparation
- new synthesis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Η εφεύρεσις αφορά μίαν νέα σύνθεσιν προς χρήσιν επί φαρμακευτικού κόκκου. Η σύνθεσις είναι επικάλυψις εκ τριών στοιβάδων, περιλαμβάνουσα ως εσωτάτην στοιβάδα ουσιαστικώς καθαρόν λίπος, ως μεσαία στοιβάδα μίγμα λίπους και πολυμερούς και ως εξωτάτην στοιβάδα και πάλιν ουσιαστικώς καθαρόν λίπος. Η σύνθεσις συμφώνως προς την εφεύρεσιν παρέχει παρασκευάσμα το οποίον είναι άγευστον, ειδικώς όταν χορηγήται υπό μορφήν κόνεως ή μίγματος, ακόμη και εάν η χορηγουμένη φαρμακευτική ύλη έχει πικράν γεύσιν. Επίσης το παρασκεύασμα διατηρείται καλώς εν μίγματι και καθιστά δυνατήν την μεταφοράν του φαρμακευτικού υλικού μετά τον στόμαχον προς απελευθέρωσιν απορρόφησιν εις την αρχήν του λεπτού εντέρου. ω
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI872051A FI77573C (fi) | 1987-05-08 | 1987-05-08 | Ny konsistens. |
Publications (2)
Publication Number | Publication Date |
---|---|
GR880100297A GR880100297A (en) | 1989-02-23 |
GR1000303B true GR1000303B (el) | 1992-05-12 |
Family
ID=8524451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR880100297A GR1000303B (el) | 1987-05-08 | 1988-05-06 | Μια νεα συνθεση επικαλυψεως καταλληλη για χρηση επι φαρμακων με την μορφη ζαχαροπηκτων. |
Country Status (35)
Country | Link |
---|---|
US (1) | US4935247A (el) |
JP (1) | JPS63287720A (el) |
KR (1) | KR880013551A (el) |
AT (1) | AT396329B (el) |
AU (1) | AU610161B2 (el) |
BE (1) | BE1000785A3 (el) |
CH (1) | CH675070A5 (el) |
CS (1) | CS270588B2 (el) |
DD (1) | DD284600A5 (el) |
DE (1) | DE3815562A1 (el) |
DK (1) | DK247588A (el) |
EG (1) | EG18603A (el) |
ES (1) | ES2006649A6 (el) |
FI (1) | FI77573C (el) |
FR (1) | FR2630912B1 (el) |
GB (1) | GB2204241B (el) |
GR (1) | GR1000303B (el) |
HU (1) | HU198621B (el) |
IL (1) | IL86313A (el) |
IS (1) | IS3339A7 (el) |
IT (1) | IT1219691B (el) |
LU (1) | LU87208A1 (el) |
MA (1) | MA21264A1 (el) |
MX (1) | MX167185B (el) |
NL (1) | NL8801185A (el) |
NO (1) | NO881993L (el) |
NZ (1) | NZ224529A (el) |
PH (1) | PH24652A (el) |
PL (1) | PL272295A1 (el) |
PT (1) | PT87429B (el) |
RO (1) | RO101402B (el) |
RU (1) | RU1836082C (el) |
SE (1) | SE8801732L (el) |
YU (1) | YU46457B (el) |
ZA (1) | ZA883239B (el) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01299226A (ja) * | 1988-05-27 | 1989-12-04 | Seikagaku Kogyo Co Ltd | サラゾスルファピリジン腸溶顆粒 |
NO882653D0 (no) * | 1988-06-15 | 1988-06-15 | Apothekernes Lab | Doseringsform. |
US5296236A (en) * | 1988-09-16 | 1994-03-22 | Recordati S.A., Chemical And Pharmaceutical Company | Controlled release therapeutic system for a liquid pharmaceutical formulations |
EP0376331A3 (en) * | 1988-12-29 | 1991-03-13 | Asahi Kogaku Kogyo Kabushiki Kaisha | Slow release drug delivery granules and process for production thereof |
US5093128A (en) * | 1989-07-18 | 1992-03-03 | Draguesku Oliver J | Rumen and other stomach chamber bypass nutrients and methods of fabrication |
JP3078859B2 (ja) * | 1990-02-23 | 2000-08-21 | 武田薬品工業株式会社 | 安定な放出制御性製剤用コーティング剤 |
US5084287A (en) * | 1990-03-15 | 1992-01-28 | Warner-Lambert Company | Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat |
DE4200821A1 (de) * | 1992-01-15 | 1993-07-22 | Bayer Ag | Geschmacksmaskierte pharmazeutische mittel |
GB9201639D0 (en) * | 1992-01-25 | 1992-03-11 | Smithkline Beecham Plc | Pharmaceutical formulations |
EP0689840A1 (de) * | 1994-06-28 | 1996-01-03 | Spirig Ag Pharmazeutische Präparate | Neues orales Erythromycinbase enthaltendes Arzneimittel |
US20020035071A1 (en) * | 1997-07-08 | 2002-03-21 | Josef Pitha | Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites |
US8563522B2 (en) * | 1997-07-08 | 2013-10-22 | The Iams Company | Method of maintaining and/or attenuating a decline in quality of life |
US20060116330A1 (en) * | 1997-07-08 | 2006-06-01 | The Iams Company | Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose |
US6242019B1 (en) | 1997-08-14 | 2001-06-05 | Warner-Lambert Company | Taste modified hard confectionery compositions containing functional ingredients |
FR2821745B1 (fr) * | 2001-03-09 | 2004-07-02 | Ethypharm Lab Prod Ethiques | Granules et granules enrobes au gout masque |
FR2821747B1 (fr) * | 2001-03-09 | 2004-07-02 | Ethypharm Lab Prod Ethiques | Suspension de telithromycine a gout masque |
US8168170B2 (en) * | 2002-10-03 | 2012-05-01 | The Procter And Gamble Company | Compositions having an inner core and at least three surrounding layers |
US20050152884A1 (en) * | 2003-12-19 | 2005-07-14 | The Procter & Gamble Company | Canine probiotic Bifidobacteria globosum |
US7785635B1 (en) | 2003-12-19 | 2010-08-31 | The Procter & Gamble Company | Methods of use of probiotic lactobacilli for companion animals |
US8877178B2 (en) * | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
US20050158294A1 (en) * | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
US8894991B2 (en) * | 2003-12-19 | 2014-11-25 | The Iams Company | Canine probiotic Lactobacilli |
US20050202079A1 (en) * | 2004-03-15 | 2005-09-15 | Mylan Pharmaceuticals Inc. | Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation |
JP4938006B2 (ja) * | 2005-05-31 | 2012-05-23 | ザ・アイムス・カンパニー | ネコ科動物プロバイオティク・ビフィドバクテリア |
JP4938005B2 (ja) * | 2005-05-31 | 2012-05-23 | ザ・アイムス・カンパニー | ネコ科動物プロバイオティックであるラクトバシラス |
WO2008093303A2 (en) | 2007-02-01 | 2008-08-07 | The Iams Company | Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE835500C (de) * | 1950-05-18 | 1952-03-31 | Otto Doerr Dipl Ing | Verfahren zum Konservieren eines in einem indifferenten Koerper gespeicherten, im Darm zur Wirkung zu bringenden Mittels |
US2828206A (en) * | 1954-02-24 | 1958-03-25 | Roseuberg Adolf | Stabilized fat-soluble vitamins and methods of making same |
US2963402A (en) * | 1955-01-18 | 1960-12-06 | Nysco Lab Inc | Sustained release medicament |
GB821790A (en) * | 1956-11-20 | 1959-10-14 | Smith Kline French Lab | Method of preparing sustained release particles and the product of the method |
US2921883A (en) * | 1957-05-03 | 1960-01-19 | Smith Kline French Lab | Novel coating material for medicaments |
NL122039C (el) * | 1960-10-20 | |||
NL297088A (el) * | 1961-01-31 | |||
BE640616A (el) * | 1962-12-19 | |||
US3256153A (en) * | 1963-02-08 | 1966-06-14 | Smith Kline French Lab | Method of stabilizing wax-fat coating materials and product thereof |
US3432593A (en) * | 1963-09-18 | 1969-03-11 | Key Pharm Inc | Delayed and sustained release type pharmaceutical preparation |
US4330338A (en) * | 1978-10-02 | 1982-05-18 | Purdue Research Foundation | Pharmaceutical coating composition, and preparation and dosages so coated |
IT1148784B (it) * | 1980-04-09 | 1986-12-03 | Eurand Spa | Procedimento per la preparazione di microcapsule in un veicolo liquido |
NZ210785A (en) * | 1984-01-13 | 1987-11-27 | Battelle Development Corp | Liquid dispersions of layered controlled release dosage forms |
US4650665A (en) * | 1985-02-08 | 1987-03-17 | Ethicon, Inc. | Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition |
DE3750369T2 (de) * | 1986-03-21 | 1995-05-24 | Eurasiam Lab | Arzneimittelzusammensetzungen. |
-
1987
- 1987-05-08 FI FI872051A patent/FI77573C/fi not_active IP Right Cessation
-
1988
- 1988-04-25 YU YU83188A patent/YU46457B/sh unknown
- 1988-04-27 MX MX011281A patent/MX167185B/es unknown
- 1988-05-05 ZA ZA883239A patent/ZA883239B/xx unknown
- 1988-05-05 EG EG250/88A patent/EG18603A/xx active
- 1988-05-06 IT IT20479/88A patent/IT1219691B/it active
- 1988-05-06 CH CH1739/88A patent/CH675070A5/de not_active IP Right Cessation
- 1988-05-06 DK DK247588A patent/DK247588A/da not_active Application Discontinuation
- 1988-05-06 LU LU87208A patent/LU87208A1/fr unknown
- 1988-05-06 CS CS883102A patent/CS270588B2/cs unknown
- 1988-05-06 AT AT0119188A patent/AT396329B/de not_active IP Right Cessation
- 1988-05-06 GB GB8810765A patent/GB2204241B/en not_active Expired - Fee Related
- 1988-05-06 SE SE8801732A patent/SE8801732L/ not_active Application Discontinuation
- 1988-05-06 DE DE3815562A patent/DE3815562A1/de not_active Withdrawn
- 1988-05-06 IS IS3339A patent/IS3339A7/is unknown
- 1988-05-06 NZ NZ224529A patent/NZ224529A/xx unknown
- 1988-05-06 KR KR1019880005287A patent/KR880013551A/ko not_active Application Discontinuation
- 1988-05-06 FR FR888806173A patent/FR2630912B1/fr not_active Expired - Fee Related
- 1988-05-06 RU SU884355822A patent/RU1836082C/ru active
- 1988-05-06 GR GR880100297A patent/GR1000303B/el unknown
- 1988-05-06 BE BE8800509A patent/BE1000785A3/fr not_active IP Right Cessation
- 1988-05-06 JP JP63111344A patent/JPS63287720A/ja active Pending
- 1988-05-06 HU HU882313A patent/HU198621B/hu not_active IP Right Cessation
- 1988-05-06 MA MA21505A patent/MA21264A1/fr unknown
- 1988-05-06 US US07/191,190 patent/US4935247A/en not_active Expired - Fee Related
- 1988-05-06 PT PT87429A patent/PT87429B/pt not_active IP Right Cessation
- 1988-05-06 PL PL27229588A patent/PL272295A1/xx unknown
- 1988-05-06 ES ES8801414A patent/ES2006649A6/es not_active Expired
- 1988-05-06 NO NO881993A patent/NO881993L/no unknown
- 1988-05-06 PH PH36902A patent/PH24652A/en unknown
- 1988-05-06 DD DD88315493A patent/DD284600A5/de not_active IP Right Cessation
- 1988-05-06 RO RO133416A patent/RO101402B/ro unknown
- 1988-05-06 NL NL8801185A patent/NL8801185A/nl not_active Application Discontinuation
- 1988-05-06 AU AU15672/88A patent/AU610161B2/en not_active Ceased
- 1988-05-09 IL IL86313A patent/IL86313A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR1000303B (el) | Μια νεα συνθεση επικαλυψεως καταλληλη για χρηση επι φαρμακων με την μορφη ζαχαροπηκτων. | |
DE3363321D1 (en) | Long-lasting three layered pharmaceutical film preparations | |
HUP0001382A2 (hu) | Eritromicinszármazékokat tartalmazó, ezek késleltetett felszabadulását biztosító készítmények | |
KR870010866A (ko) | 펄프(pulse)식 약제 전달용 투약형상체 | |
DE69015207D1 (de) | Liposomenmikroreservoirzusammensetzung und -verfahren. | |
US4301176A (en) | Method of administering calcium valproate | |
ATE122668T1 (de) | Diarylsubstituierte heterocyclische verbindung, ihre herstellung und arzneimittel und kosmetika daraus. | |
ES2062392T3 (es) | Medicamentos que comprenden salmeterol y fluticasona. | |
CA2219991A1 (en) | Taste masking pharmaceutical composition for oral administration | |
ATE526950T1 (de) | Hydrocodon-formulierungen mit gesteuerter freisetzung | |
GR1000074B (el) | Λιποειδη σφαιριδια (κυστιδια) για ενδοπεριτονειακη χορηγηση θεραπευτικων παραγοντων. | |
AU3345197A (en) | Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof | |
ATE120642T1 (de) | Zubereitung zur transdermalen verabreichung von arzneimitteln. | |
AR011133A1 (es) | MICROGRÁNULOS DE LIBERACIoN CONTROLADA QUE CONTIENEN CISPLATINO , PROCEDIMIENTO DE SU PREPARACIoN, COMPOSICIoN FARMACÉUTICA Y UTILIZACIoN EN LA FABRICACIoN DE UN MEDICAMENTO POLIQUIMIOTERAPIA O EN ASOCIACIoN CON UNA RADIOTERAPIA. | |
DE69002718D1 (de) | Medikamente. | |
NO890186L (no) | Fremgangsmaate for fremstilling av en avgivelses- og/ellerdoseringsform for legemiddelaktive stoffer. | |
EP0177342A3 (en) | Oral formulation of therapeutic proteins | |
ES2033021T3 (es) | Agente con efecto destructivo a tumores malignos, procedimiento para su obtencion y preparacion para la aplicacion en la terapia de enfermos de cancer. | |
US5852057A (en) | Anticarcinogenic drug composition | |
JPS6136491B2 (el) | ||
KR950013513A (ko) | 약제 제조용 모에노마이신 및 이의 유도체, 및 모에노마이신 또는 이의 유도체를 함유하는 약제 | |
SE8601457D0 (sv) | Compositions of liposomes and b?712-receptor active substances for inhalation | |
AR002727A1 (es) | El uso de ridogrel para la fabricacion de un medicamento util para el tratamiento de enfermedades digestivas inflamatorias, una composicionfarmaceutica que comprende ridogrel y un procedimiento para preparar dicha composicion. | |
JPS577422A (en) | Crocosmia aurea "plach" | |
ES2028279T3 (es) | Un procedimiento para preparar una mezcla farmaceutica sinergica. |